Neurobiology of Aging
Volume 27, Issue 12 , Pages 1807-1815 , December 2006

Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt–Jakob disease

Received 28 August 2005 ,Revised 8 October 2005 ,Accepted 18 October 2005.

References 

  1. Aguzzi A, Montrasio F, Kaeser PS. Prions: health scare and biological challenge. Nat Rev Mol Cell Biol. 2001;2:118–126
  2. Andreoletti O, Levavasseur E, Uro-Coste E, Tabouret G, Sarradin P, Delisle M-B, et al. Astrocytes accumulate 4-hydroxynonenal adducts in murine scrapie and human Creutzfeldt–Jakob disease. Neurobiol Dis. 2002;11:386–393
  3. Arlt S, Kontush A, Zerr I, Buhmann C, Jacobi C, Schroter A, et al. Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt–Jakob disease. Neurobiol Dis. 2002;10:150–156
  4. Bio KF, Dal Pizzol F, Conte da Frota ML, Walz R, Andrades ME, da Silva EG, et al. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med. 2001;30:1137–1144
  5. Bleich S, Kropp S, Degner D, Zerr I, Pilz J, Gleiter CH, et al. Creutzfeldt–Jakob disease and oxidative stress. Acta Neurol Scand. 2000;101:332–334
  6. Bratosiewicz-Wasik J, Wasik TJ, Liberski PP. Molecular approaches to mechanisms of prion diseases. Folia Neuropathol. 2004;42:S33–S46
  7. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al. The cellular prion protein binds copper in vivo. Nature. 1997;390:684–687
  8. Brown DR, Schulz-Schaeffer WJ, Schmidt B, Krtezschmar HA. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol. 1997;146:104–112
  9. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM. Normal prion protein has an activity like that of superoxide dismutase. Biochem J. 1999;344(Pt 1):1–5
  10. Budka H, Head MW, Ironside JW, Gambetti P, Parchi P, Zeidler M, et al. Sporadic Creutzfeldt–Jakob disease. In:  Dickson D editors. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003;p. 287–297
  11. Butterfield DA. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res. 2004;1000:1–7
  12. Butterfield DA, Booyd-Kimbel D, Castegna A. Proteomics in Alzheimer's disease; insights into mechanisms of neurodegeneration. J Neurochem. 2003;86:1313–1327
  13. Choi SI, Ju WK, Choi EK, Kim J, Lea HZ, Carp RI, et al. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263K scrapie agent. Acta Neuropathol. 1998;96:279–286
  14. Choi YG, Kim JI, Lee HP, Jin JK, Choi EK, Carp RI, et al. Induction of heme oxygenase-1 in the brain of scrapie-infected mice. Neurosci Lett. 2000;289:173–176
  15. Collinge J. Prion diseases of human and animals. Their causes and molecular basis. Annu Rev Neurosci. 2001;24:519–550
  16. Dalfó E, Portero-Otín M, Ayala V, Martínez A, Pamplona R, Ferrer I. Evidence of oxidative stress in the noecortex in incidental Lewy body disease. J Neuropathol Exp Neurol. 2005;64:1–15
  17. DeArmond SJ, Kretzschmar HA, Prusiner SB. Prion diseases. In: Graham DI, Lantos PL, editors. Greenfield's neuropahology, vol. II. London, New York, New Delhi: Arnold; 2003. p. 273–323.
  18. Ferrer I. Differential expression of phosphorylated translation initiator factor 2α in Alzheimer's disease and Creutzfeldt–Jakob disease. Neuropathol Appl Neurobiol. 2002;28:441–451
  19. Guentchev M, Siedlak SL, Jarius C, Tagliavini F, Castellani RJ, Perry G, et al. Oxidative damage to nucleic acids in human prion disease. Neurobiol Dis. 2002;9:275–281
  20. Guentchev M, Voigtlander T, Haberler C, Groschup MH, Budka H. Evidence of oxidative stress in experimental prion disease. Neurobiol Dis. 2000;7:270–273
  21. Keshet GI, Ovadia H, Taraboulos A, Gabizon R. Scrapie-infected mice and PrP knockout mice share abnormal localization and activity of neuronal nitric oxide synthase. J Neurochem. 1999;72:1224–1231
  22. Kim JI, Choi SI, Kim NH, Jin JK, Choi EK, Carp RI, et al. Oxidative stress and neurodegeneration in prion diseases. Ann N Y Acad Sci. 2001;928:182–186
  23. Knight RSG, Will RG. Prion diseases. J Neurol Neurosurg Psychiat. 2004;75:S136–S142
  24. Lauderback CM, Hackett JM, Huang EF, Keller JN, Szweda LL, Markesbery WK, et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of A1-42. J Neurochem. 2001;78:413–416
  25. Lee DW, Sohn HO, Lim YG, Lee HM, Kim YS, Carp RI, et al. Alteration of free radical metabolism in the brain of mice infected with scrapie agent. Free Radic Res. 1999;30:499–507
  26. Milhavet O, Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Rev. 2002;38:328–339
  27. Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mange A, et al. Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA. 2000;97:13937–13942
  28. Omar RA, Chyan YJ, Andorn AC, Poggeler B, Robakis NK, Pappolla MA. Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. J Alzheimer Dis. 1999;1:139–145
  29. Ovadia H, Rosenmann H, Shezen E, Halimi M, Ofran I, Gabizon R. Effect of scrapie infection on the activity of neuronal nitric-oxide synthase in brain and neuroblastoma cells. J Biol Chem. 1996;271:16856–16861
  30. Pamplona R, Dalfó E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, et al. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J Biol Chem. 2005;280:21522–21530
  31. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–233
  32. Petersen RB, Siedlak SL, Lee HG, Kim NY, Nunomura A, Tagliavini F, et al. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol. 2005;110:232–238
  33. Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin R, Butterfield DA. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice—a model of familial Parkinson's disease. Neurobiol Dis. 2005;18:492–498
  34. Prusiner SB. The prion diseases of humans and animals. In:  Rosenber RN,  Prusiner SB,  DiMauro S,  Barchi RL editor. The molecular and genetic basis of neurological diseases. Boston, Oxford, Johannesburg, Melbourne, New Delhi, Singapore: Butterworth-Heinemann; 1997;p. 165–186
  35. Sakudo A, Lee D, Saeki K, Nakamura Y, Inoue K, Matsumoto Y, et al. Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem Biophys Res Commun. 2003;308:660–667
  36. Sasaki N, Takeuchi M, Chowei H, Kikuchi S, Hayashi Y, Nakano N, et al. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt–Jakob disease with prion plaques. Neurosci Lett. 2002;326:117–120
  37. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation-end products and its ligand. Biochem Biophys Acta. 2000;1498:99–111
  38. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108:949–955
  39. Sultana R, Butterfield DA. Identification of oxidatively modified GST and MRP1 in Alzheimer's disease brain. Neurochem Res. 2004;29:2215–2220
  40. Van Everbroeck B, Dobbeleir I, De Waele M, de Leenheir E, Lübke U, Martin J-J, et al. Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt–Jakob and Alzheimer's disease. Acta Neuropathol. 2004;108:194–200
  41. White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM, et al. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol. 1999;155:1723–1730
  42. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, et al. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem. 2001;76:565–572
  43. Wong BS, Pan T, Liu T, Li R, Petersen RB, Jones IM, et al. Prion disease: a loss of antioxidant functions?. Biochem Biophys Res Commun. 2000;275:249–252

PII: S0197-4580(05)00335-0

doi: 10.1016/j.neurobiolaging.2005.10.006

Neurobiology of Aging
Volume 27, Issue 12 , Pages 1807-1815 , December 2006

Article Tools

* Image Usage & Resolution